✦ LIBER ✦

The safety of breast-conserving surgery in patients who achieve a complete pathologic response after neoadjuvant chemotherapy

✍ Scribed by Florentia Peintinger; W. Fraser Symmans; Ana M. Gonzalez-Angulo; Judy C. Boughey; Aman U. Buzdar; T. Kuan Yu; Kelly K. Hunt; S. Eva Singletary; Gildy V. Babiera; Anthony Lucci; Funda Meric-Bernstam; Henry M. Kuerer

Publisher: John Wiley and Sons
Year: 2006
Tongue: English
Weight: 109 KB
Volume: 107
Category: Article
ISSN: 0008-543X
DOI: 10.1002/cncr.22111

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Molecular classification system identifi

Molecular classification system identifies invasive breast carcinoma patients who are most likely and those who are least likely to achieve a complete pathologic response after neoadjuvant chemotherapy

✍ Neal S. Goldstein; David Decker; Dawn Severson; Scott Schell; Frank Vicini; Jeff 📂 Article 📅 2007 🏛 John Wiley and Sons 🌐 English ⚖ 121 KB 👁 1 views

## Abstract ## BACKGROUND. The molecular classification system categorizes invasive breast carcinomas according to their key driving biomarkers. In the current study, the authors evaluated whether response to neoadjuvant chemotherapy was correlated with the molecular classification groups. ## MET

Pathologic complete response in breast c

Pathologic complete response in breast cancer patients receiving anthracycline- and taxane-based neoadjuvant chemotherapy : Evaluating the effect of race/ethnicity

✍ Mariana Chavez-MacGregor; Jennifer Litton; Huiqin Chen; Sharon H. Giordano; Clif 📂 Article 📅 2010 🏛 John Wiley and Sons 🌐 English ⚖ 298 KB 👁 2 views

Only pathologic complete response to neo

Only pathologic complete response to neoadjuvant chemotherapy improves significantly the long term survival of patients with resectable esophageal squamous cell carcinoma : Final report of a randomized, controlled trial of preoperative chemotherapy versus surgery alone

✍ Ermanno Ancona; Alberto Ruol; Stefano Santi; Stefano Merigliano; Vanna Chiarion 📂 Article 📅 2001 🏛 John Wiley and Sons 🌐 English ⚖ 151 KB 👁 2 views

Phase 2 trial of primary systemic therap

Phase 2 trial of primary systemic therapy with doxorubicin and docetaxel followed by surgery, radiotherapy, and adjuvant chemotherapy with cyclophosphamide, methotrexate, and 5-fluorouracil based on clinical and pathologic response in patients with stage IIB to III breast cancer : Long-term results from The University of Texas M. D. Anderson Cancer Center Study ID97-099

✍ Ricardo H. Alvarez; Daniel J. Booser; Massimo Cristofanilli; Aysegul A. Sahin; E 📂 Article 📅 2010 🏛 John Wiley and Sons 🌐 English ⚖ 199 KB 👁 2 views